Erythromycin, 4′′-O-methyl- is a semi-synthetic macrolide antibiotic derived from erythromycin, which is produced by the bacterium Saccharopolyspora erythraea. This compound is characterized by its ability to inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit, making it effective against a variety of Gram-positive and some Gram-negative bacteria. The modification at the 4′′ position enhances its stability and bioavailability compared to its parent compound. Erythromycin, 4′′-O-methyl- exhibits a broad spectrum of activity, making it useful in treating respiratory tract infections, skin infections, and certain sexually transmitted diseases. It is typically administered orally or intravenously, depending on the severity of the infection. The substance is also known for its potential side effects, which may include gastrointestinal disturbances and allergic reactions. As with other antibiotics, the emergence of resistance is a concern, necessitating careful use and adherence to prescribed regimens. Overall, this compound represents an important tool in antimicrobial therapy.

Erythromycin, 4′′-O-methyl-

200802-92-2: Erythromycin, 4′′-O-methyl- is a semi-synthetic macrolide antibiotic derived from erythromycin, which is produced by the bacterium Saccharopolyspora erythraea. This compound is characterized by its ability to inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit, making it effective against a variety of Gram-positive and some Gram-negative bacteria. The modification at the 4′′ position enhances its stability and bioavailability compared to its parent compound. Erythromycin, 4′′-O-methyl- exhibits a broad spectrum of activity, making it useful in treating respiratory tract infections, skin infections, and certain sexually transmitted diseases. It is typically administered orally or intravenously, depending on the severity of the infection. The substance is also known for its potential side effects, which may include gastrointestinal disturbances and allergic reactions. As with other antibiotics, the emergence of resistance is a concern, necessitating careful use and adherence to prescribed regimens. Overall, this compound represents an important tool in antimicrobial therapy.

CAS 200802-92-2

Erythromycin, 4′′-O-methyl-

Erythromycin, 4''-O-methyl

Ref: ST-EA-CP-E18067